Form 4: Omada Health CFO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Omada Health's Chief Financial Officer, Steven L. Cook, sold 6,800 shares of common stock for a weighted average price of $17.2329 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Steven L. Cook, Chief Financial Officer of Omada Health, Inc., reported a sale of common stock.
- The transaction involved the disposition of 6,800 shares.
- The shares were sold at a weighted average price of $17.2329 per share.
- The sale was executed on June 15, 2026.
- This transaction was conducted pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026.
- Following the transaction, Steven L. Cook beneficially owns 187,209 shares of Omada Health common stock.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a moderately negative signal, as an insider sale, even under a 10b5-1 plan, can suggest a lack of strong upside conviction from a key executive.
Negatives
- An insider, the Chief Financial Officer, sold 6,800 shares of common stock.
- While executed under a 10b5-1 plan, insider sales can sometimes be perceived negatively by the market as they might suggest a lack of confidence or a desire to diversify.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider sales, even those pre-arranged under a 10b5-1 plan, are routinely monitored by investors for potential signals regarding management's perception of future company performance. While 10b5-1 plans are designed to avoid accusations of trading on material non-public information, the timing of their adoption and the volume of sales are still scrutinized.
Stakeholder Impact
- Shareholders may interpret the insider sale as a signal regarding the company's future prospects, potentially influencing their investment decisions.
Key Dates
| Date | Description |
|---|---|
| 03/14/2026 | Date 10b5-1 trading plan was adopted by Steven L. Cook. |
| 06/15/2026 | Date of transaction (sale of common stock). |
| 06/16/2026 | Date the Form 4 was signed. |
Recommendation
holdThe sale by the CFO, even under a 10b5-1 plan, introduces a degree of caution. However, without additional fundamental information or a pattern of widespread insider selling, a 'hold' recommendation is appropriate, suggesting investors monitor future insider activity and company performance closely.
Keywords
Omada Health, OMDA, Steven L. Cook, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.